SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
New Technology Acquisition Holdings (NTAC) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 80/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NTAC
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.31
Book Value / Share$0.00
Revenue / Share$0.70
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$0.00 |
$20K |
$-24.71K |
-123.5% |
| 2015 |
$0.00 |
$4.17K |
$-203.47K |
-4882.9% |
| 2016 |
$-0.01 |
$8.39K |
$-278.55K |
-3322% |
| 2017 |
$0.00 |
$69.71K |
$-98.9K |
-141.9% |
| 2018 |
$0.04 |
$18.96M |
$1.85M |
9.7% |
| 2019 |
$0.26 |
$76.01M |
$14.16M |
18.6% |
| 2020 |
$0.33 |
$118.39M |
$21.62M |
18.3% |
| 2021 |
$-0.28 |
$104.82M |
$-14.02M |
-13.4% |
| 2022 |
$0.07 |
$14.07M |
$6.01M |
42.7% |
| 2023 |
$0.31 |
$59.65M |
$26.97M |
45.2% |
